“Examining the Senate and House Versions of the 'Greater Access to Affordable Pharmaceuticals Act'”

July 25 , 2003

NOTICE OF FULL COMMITTEE HEARING-- RESCHEDULEMENT

The hearing on "Examining the Senate and House Versions of the 'Greater Access to Affordable Pharmaceuticals Act'" scheduled by the Senate Committee on the Judiciary for Thursday, July 24, 2003, at 2:00 p.m. has been rescheduled for Friday, August 1, 2003 at 9:30 a.m. in Room 226 of the Dirksen Senate Office Building.

By order of the Chairman

----------

Witness List
Hearing Before the Committee on the Judiciary
United States Senate

on

"Examining the Senate and House Versions of the 'Greater Access to
Pharmaceuticals Act'"

Friday, August 1, 2003
9:30 am, 226 Dirksen Senate Office Building

Panel I

The Honorable Timothy J. Muris, Esq.
Chairman
Federal Trade Commission
Washington, D. C.

Mr. Jon W. Dudas
Deputy Under Secretary for Intellectual Property
Deputy Director of the United States Patent and Trademark Office
Department of Commerce
Arlington, Virginia

Mr. Dan Troy, Esq.
Chief Counsel for Food and Drugs
Food and Drug Administration
Rockville, MD

Mr. Sheldon T. Bradshaw
Deputy Assistant Attorney General
Office of Legal Counsel
Department of Justice
Washington, D.C.

Panel II

Mr. Robert Armitage
Vice President and General Counsel
Eli Lilly and Company
Washington, D.C.